The Rogosin Institute, Weill Cornell Medical College — New York, New York

The Rogosin Institute, Weill Cornell Medical College is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

The Rogosin Institute, Weill Cornell Medical College has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Homozygous Familial Hypercholesterolemia.

Sponsors: The Rogosin Institute.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Rogosin Institute, Weill Cornell Medical College?

The Rogosin Institute, Weill Cornell Medical College has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Rogosin Institute, Weill Cornell Medical College conducted?

The Rogosin Institute, Weill Cornell Medical College has 1 clinical trials on record, with 1 currently active. Their work covers Homozygous Familial Hypercholesterolemia.

Is The Rogosin Institute, Weill Cornell Medical College accredited by Crixeo Health?

The Rogosin Institute, Weill Cornell Medical College has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Rogosin Institute, Weill Cornell Medical College?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.